These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12509624)

  • 1. Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus.
    Ho CY; Wong CK; Li EK; Tam LS; Lam CW
    Rheumatology (Oxford); 2003 Jan; 42(1):117-22. PubMed ID: 12509624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus.
    Svenungsson E; Cederholm A; Jensen-Urstad K; Fei GZ; de Faire U; Frostegård J
    Scand J Rheumatol; 2008; 37(5):352-9. PubMed ID: 18666029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent increase in plasma thrombomodulin in patients with a history of lupus nephritis: endothelial cell activation markers.
    Frijns R; Fijnheer R; Schiel A; Donders R; Sixma J; Derksen R
    J Rheumatol; 2001 Mar; 28(3):514-9. PubMed ID: 11296951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis.
    Kaplanski G; Cacoub P; Farnarier C; Marin V; Grégoire R; Gatel A; Durand JM; Harlé JR; Bongrand P; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):55-64. PubMed ID: 10643700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus.
    Parodis I; Gokaraju S; Zickert A; Vanarsa K; Zhang T; Habazi D; Botto J; Serdoura Alves C; Giannopoulos P; Larsson A; Svenungsson E; Gunnarsson I; Mohan C
    Rheumatology (Oxford); 2020 Sep; 59(9):2237-2249. PubMed ID: 31722419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum thrombomodulin-a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity.
    Boehme MW; Raeth U; Galle PR; Stremmel W; Scherbaum WA
    Clin Exp Immunol; 2000 Jan; 119(1):189-95. PubMed ID: 10606982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese women.
    Porreca E; Di Febbo C; Fusco L; Moretta V; Di Nisio M; Cuccurullo F
    Atherosclerosis; 2004 Jan; 172(1):175-80. PubMed ID: 14709373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between serum vascular cell adhesion molecule-1 and endothelin-1 levels with organ involvement and disease activity in systemic lupus erythematosus patients.
    Hajialilo M; Tayari P; Ghorbanihaghjo A; Khabbazi A; Malek Mahdavi A; Rashtchizadeh N
    Lupus; 2018 Oct; 27(12):1918-1925. PubMed ID: 30157717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis.
    el-Gamal YM; Heshmat NM; el-Kerdany TH; Fawzy AF
    Pediatr Allergy Immunol; 2004 Jun; 15(3):270-7. PubMed ID: 15209962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble vascular cell adhesion molecule-1 indicates SLE disease activity and specific organ involvement.
    Pizarro S; Monárrez Espino J; Ruiz A; Jara LJ; Nava A; Riebeling-Navarro C
    Rev Alerg Mex; 2007; 54(6):189-95. PubMed ID: 18693542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
    Cieślik P; Hrycek A
    Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
    Kuryliszyn-Moskal A; Klimiuk PA; Ciolkiewicz M; Sierakowski S
    J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early vascular alterations in SLE and RA patients--a step towards understanding the associated cardiovascular risk.
    Santos MJ; Carmona-Fernandes D; Canhão H; Canas da Silva J; Fonseca JE; Gil V
    PLoS One; 2012; 7(9):e44668. PubMed ID: 22962622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
    Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated soluble intercellular adhesion molecule-1 levels in patients with systemic lupus erythematosus: relation to insulin resistance.
    Tso TK; Huang WN
    J Rheumatol; 2007 Apr; 34(4):726-30. PubMed ID: 17309130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of hemostatic markers and thrombomodulin in systemic lupus erythematosus: evidence for a prothrombotic state.
    Kiraz S; Ertenli I; Benekli M; Haznedaroğlu IC; Calgüneri M; Celik I; Apraş S; Kirazli S
    Lupus; 1999; 8(9):737-41. PubMed ID: 10602446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus.
    Wong CK; Ho CY; Li EK; Tam LS; Lam CW
    Clin Exp Immunol; 2002 Nov; 130(2):345-51. PubMed ID: 12390326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1.
    Lewis MJ; Vyse S; Shields AM; Zou L; Khamashta M; Gordon PA; Pitzalis C; Vyse TJ; D'Cruz DP
    Arthritis Res Ther; 2016 Jan; 18():5. PubMed ID: 26746423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T; Fierz W; Stoll T; Villiger PM
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
    Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.